These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 25818756)

  • 1. Late-acquired scaffold malapposition and discontinuity that may be attributable to pathological coronary ectasia: Insights from optical coherence tomography.
    Miyazaki T; Ruparelia N; Kawamoto H; Sato K; Latib A; Colombo A
    Int J Cardiol; 2015; 186():136-8. PubMed ID: 25818756
    [No Abstract]   [Full Text] [Related]  

  • 2. The Absorb Limits.
    Gómez Menchero AE; Camacho Freire SJ; Díaz Fernández JF; Roa Garrido J; León Jiménez J; Cardenal Piris R
    J Invasive Cardiol; 2016 Oct; 28(10):E122-E123. PubMed ID: 27705895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Late Malapposition After Bare-Metal Stent, But Not Bioresorbable Scaffold: Insights on Intraindividual Heterogeneity in Plaque and Device Response.
    Cortese B; Buccheri D; Silva Orrego P; Biondi-Zoccai G
    J Invasive Cardiol; 2015 Aug; 27(8):E171-2. PubMed ID: 26232021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neointimal proliferation is associated with clinical restenosis 2 years after fully bioresorbable vascular scaffold implantation.
    Indolfi C; Mongiardo A; Spaccarotella C; Caiazzo G; Torella D; De Rosa S
    Circ Cardiovasc Imaging; 2014 Jul; 7(4):755-7. PubMed ID: 25027457
    [No Abstract]   [Full Text] [Related]  

  • 5. Restenosis of Coronary Bioresorbable Vascular Scaffolds.
    Alfonso F; García-Guimaraes M
    Rev Esp Cardiol (Engl Ed); 2017 Jul; 70(7):527-531. PubMed ID: 28285939
    [No Abstract]   [Full Text] [Related]  

  • 6. Angiographic and optical coherence tomography insights into bioresorbable scaffold thrombosis: single-center experience.
    Karanasos A; Van Mieghem N; van Ditzhuijzen N; Felix C; Daemen J; Autar A; Onuma Y; Kurata M; Diletti R; Valgimigli M; Kauer F; van Beusekom H; de Jaegere P; Zijlstra F; van Geuns RJ; Regar E
    Circ Cardiovasc Interv; 2015 May; 8(5):. PubMed ID: 25969547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fully bioresorption of an Absorb bioresorbable vascular scaffold after scaffold restenosis.
    Goncalves-Ramírez LR; Gutiérrez H; Rojas P; Cortés C; Serrador A; Ramos B; Toro J; Amat-Santos IJ; San Román JA
    Cardiol J; 2019; 26(2):209-211. PubMed ID: 31032876
    [No Abstract]   [Full Text] [Related]  

  • 8. First reported use of drug-coated balloon for bioresorbable in-scaffold restenosis.
    Latini RA; Buccheri D; Cortese B
    Catheter Cardiovasc Interv; 2017 Mar; 89(4):676-678. PubMed ID: 27649683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optical coherence tomography assessment of late intra-scaffold dissection: a new challenge of bioresorbable scaffolds.
    Ohno Y; Mangiameli A; Attizzani GF; Capodanno D; Tamburino C
    JACC Cardiovasc Interv; 2015 Jan; 8(1 Pt A):e11-2. PubMed ID: 25499307
    [No Abstract]   [Full Text] [Related]  

  • 10. An autopsy case of sudden cardiac death due to in-scaffold restenosis and late-scaffold thrombosis after bioresorbable vascular scaffold implantation; back to past stent era?
    Asakura K; Hao H
    Eur Heart J; 2017 Sep; 38(33):2571. PubMed ID: 28651349
    [No Abstract]   [Full Text] [Related]  

  • 11. Malabsorption of a Bioresorbable Vascular Scaffold System Leading to Very Late In-Scaffold Restenosis More Than 3.5 Years After Implantation: Assessment by Optical Coherence Tomography.
    Dommasch M; Langwieser N; Laugwitz KL; Ibrahim T
    JACC Cardiovasc Interv; 2016 Dec; 9(24):2571-2572. PubMed ID: 27889344
    [No Abstract]   [Full Text] [Related]  

  • 12. Incidence and imaging outcomes of acute scaffold disruption and late structural discontinuity after implantation of the absorb Everolimus-Eluting fully bioresorbable vascular scaffold: optical coherence tomography assessment in the ABSORB cohort B Trial (A Clinical Evaluation of the Bioabsorbable Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions).
    Onuma Y; Serruys PW; Muramatsu T; Nakatani S; van Geuns RJ; de Bruyne B; Dudek D; Christiansen E; Smits PC; Chevalier B; McClean D; Koolen J; Windecker S; Whitbourn R; Meredith I; Garcia-Garcia HM; Veldhof S; Rapoza R; Ormiston JA
    JACC Cardiovasc Interv; 2014 Dec; 7(12):1400-11. PubMed ID: 25523532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of in-stent restenosis with bioresorbable vascular scaffolds: optical coherence tomography insights.
    Rivero F; Bastante T; Cuesta J; Benedicto A; Restrepo JA; Alfonso F
    Can J Cardiol; 2015 Mar; 31(3):255-9. PubMed ID: 25660152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of Very Late Bioresorbable Scaffold Thrombosis: The INVEST Registry.
    Yamaji K; Ueki Y; Souteyrand G; Daemen J; Wiebe J; Nef H; Adriaenssens T; Loh JP; Lattuca B; Wykrzykowska JJ; Gomez-Lara J; Timmers L; Motreff P; Hoppmann P; Abdel-Wahab M; Byrne RA; Meincke F; Boeder N; Honton B; O'Sullivan CJ; Ielasi A; Delarche N; Christ G; Lee JKT; Lee M; Amabile N; Karagiannis A; Windecker S; Räber L
    J Am Coll Cardiol; 2017 Nov; 70(19):2330-2344. PubMed ID: 29096803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How should I treat a bioresorbable vascular scaffold edge restenosis and intra-scaffold dissection?
    Fallesen CO; Antonsen L; Thayssen P; Jensen LO; Lee PH; Lee SW; Park SJ; Moscarella E; Spitaleri G; Brugaletta S
    EuroIntervention; 2018 Feb; 13(14):1730-1734. PubMed ID: 29465408
    [No Abstract]   [Full Text] [Related]  

  • 16. Optical Coherence Tomography of Magnesium Bioresorbable Scaffold Restenosis.
    García-Blas S; Miñana G; Sanchis J
    Rev Esp Cardiol (Engl Ed); 2018 Dec; 71(12):1069. PubMed ID: 29223376
    [No Abstract]   [Full Text] [Related]  

  • 17. Disappearing stent but persisting problems? Optical coherence tomography assessment of intra-scaffold restenosis.
    Conrotto F; Pavani M; D'Ascenzo F; Gaita F
    Int J Cardiol; 2016 Jan; 203():726-7. PubMed ID: 26587728
    [No Abstract]   [Full Text] [Related]  

  • 18. Bioresorbable vascular scaffold implantation for treatment of recurrent in-stent restenosis: insights from optical coherence tomography.
    Camuglia AC; Lavi S
    Int J Cardiol; 2014 Mar; 172(1):238-9. PubMed ID: 24447733
    [No Abstract]   [Full Text] [Related]  

  • 19. [Role of bioresorbable scaffold and optical coherence tomography in the treatment of recurrent in-stent restenosis: a case report].
    Mattesini A; Dall'Ara G; Rama-Merchan JC; Ghione M; Foin N; Secco GG; Di Mario C
    G Ital Cardiol (Rome); 2013 Dec; 14(12):836-8. PubMed ID: 24336600
    [No Abstract]   [Full Text] [Related]  

  • 20. Bioresorbable vascular scaffold strut disruption after crossing with an optical coherence tomography imaging catheter.
    Sato K; Panoulas VF; Naganuma T; Miyazaki T; Latib A; Colombo A
    Int J Cardiol; 2014 Jul; 174(3):e116-9. PubMed ID: 24814543
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.